FDA Publishes Final Guidance For Communicating Off-Label Uses. First Amendment Questions Remain

The US FDA final guidance uses a Q&A format to help manufacturers navigate the regulatory landscape for communicating the off-label uses of their medical products to health care professionals. However, some say the final document fails to address potential free speech concerns.